Johnson N P, Watson A
University Department of Obstetrics & Gynaecology, National Women's Hospital, Auckland, New Zealand.
Hum Reprod Update. 2000 May-Jun;6(3):259-67. doi: 10.1093/humupd/6.3.259.
The objectives of the study was to determine the effectiveness of post-operative procedures following female pelvic reproductive surgery. A systematic review employing the principles of the Cochrane Menstrual Disorders and Subfertility Group was used. Five randomized controlled trials were included. Participants were women undergoing pelvic reproductive surgery; interventions were any post-operative procedure designed to improve fertility; outcomes were pregnancy, live birth, ectopic pregnancy and miscarriage rates and the rates of tubal patency and procedure-related complications. Summary statistics were expressed as odds ratios. The results showed that the odds of pregnancy, live birth, ectopic pregnancy and miscarriage were not significantly altered by post-operative hydrotubation nor second-look laparoscopy with adhesiolysis. Whether hydrotubation was early or late and whether hydrotubation fluid contained steroid or not had no significant impact on the odds of pregnancy, live birth, ectopic pregnancy or miscarriage. The odds of pregnancy and live birth were significantly increased and infective complications significantly decreased by hydrotubation with fluid containing antibiotic compared with hydrotubation with fluid containing no antibiotic, in late hydrotubation following tubal stent removal 6 weeks after tubal surgery. The odds of at least one patent Fallopian tube were significantly increased with late hydrotubation following tubal stent removal compared with early hydrotubation in women who had no tubal stenting, but this intervention had no significant impact on the odds of pregnancy, live birth, ectopic pregnancy or miscarriage. In conclusion, there is insufficient evidence to support the routine practice of hydrotubation or second-look laparoscopy following female pelvic reproductive surgery. The studies on which this conclusion is based were either poor quality or underpowered. Post-operative hydrotubation with fluid containing antibiotic following tubal surgery may offer benefit over hydrotubation fluid without antibiotic. A randomized controlled trial of post-operative hydrotubation with antibiotic-containing fluid versus no hydrotubation for improving fertility following tubal surgery is justified.
该研究的目的是确定女性盆腔生殖手术后的术后程序的有效性。采用了Cochrane月经紊乱与不育症小组的原则进行系统评价。纳入了五项随机对照试验。参与者为接受盆腔生殖手术的女性;干预措施为任何旨在提高生育能力的术后程序;结果指标为妊娠、活产、宫外孕和流产率以及输卵管通畅率和与手术相关的并发症发生率。汇总统计数据以比值比表示。结果显示,术后输卵管通液术和粘连松解的二次腹腔镜检查并未显著改变妊娠、活产、宫外孕和流产的几率。输卵管通液术是早是晚以及通液液中是否含有类固醇对妊娠、活产、宫外孕或流产的几率均无显著影响。与不含抗生素的通液相比,在输卵管手术后6周取出输卵管支架后的晚期通液中,含抗生素的通液显著增加了妊娠和活产的几率,并显著降低了感染性并发症的发生率。在未放置输卵管支架的女性中,与早期通液相比,输卵管支架取出后的晚期通液显著增加了至少一侧输卵管通畅的几率,但该干预措施对妊娠、活产、宫外孕或流产的几率没有显著影响。总之,没有足够的证据支持女性盆腔生殖手术后常规进行输卵管通液术或二次腹腔镜检查。得出该结论所依据的研究质量要么较差,要么样本量不足。输卵管手术后使用含抗生素的液体进行术后输卵管通液可能比使用不含抗生素的通液更有益。对输卵管手术后使用含抗生素液体进行术后输卵管通液与不进行输卵管通液以提高生育能力进行随机对照试验是合理的。